维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Hamdy NA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Osteoprotegerin as a potential therapy for osteoporosis 显示文摘	Hamdy NA	2005	Curr Osteoporos Rep2005，3，4：	1
2	Effects of up to 15 years of recombinant human GH (rh- GH) replacement on bone metabolism in adults with growth hormone deficiency (GHD) : the Leiden Cohort Study 显示文摘	Appelman-Dijkstra NM Claessen KM Hamdy NA	2014	Clin Endocrinol (Oxf)2014，81，5：	1
3	Targeting the RANK/RANKL/OPG signaling pathway : a novel approach in the management of osteoporosis显示文摘	Hamdy NA	2007	Curr Opin Investig Drugs2007，8，4：	1
4	Effectsof up to 15 years of recombinant human GH ( rhGH) replacementon bone metabolism in adults with growth hormone deficiency(GHD) : the Leiden Cohort Study 显示文摘	Appelman-Dijkstra NM Claessen KM Hamdy NA	2014	Clin Endocrinol ( Oxf)2014，81，5：	1
5	Denosumab : RANKL inhibition in the management of bone loss显示文摘	Hamdy NA	2008	Drugs Today (Barc)2008，44，1：	1
6	The role of vitamin D in human fracture healing: a systematic review of the literature显示文摘	Gorter EA Hamdy NA Appelman-Dijkstra NM	2014	Bone2014，64，：	1
7	Modulation of carcinogen metabolizing enzymes by new fused heterocycles pendant to 5,6,7,8-tetrahydronaphthalene derivatives显示文摘	Hamdy NA Gamal-Eldeen AM Abdel-Aziz HA	2010	Eur J Med Chem2010，45，2：	1
8	Distinct effects of p ioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus显示文摘	van Lierop A Hamdy NA van der Meer RW	2012	Eur J Endocrinol2012，166，4：	1
9	A patient with persistent primary hyperparathy midism due to a second ectopic adenoma显示文摘	Hamdy NA	2007	Nat Clin Pract Endocfind Metab2007，3，3：	1
10	The effects of thyrotropin-suppressive therapy on bone metabolism in pa tients with well-differentiated thyroid carcinoma 显示文摘	Heemstra KA Hamdy NA Romijn JA	2006	Thyroid2006，16，6：	1
11	Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury显示文摘	Kishk NA Gabr H Hamdy S		0，，08：	1
12	The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma显示文摘	Heemstra KA Hamdy NA Romijn JA	2006	Thyroid2006，16，6：	1
13	Targeting the RANK/RANKL/OPG signaling pathway:a novel approach in the management of osteoporosis显示文摘	Hamdy NA	2007	J Curr Opin Investing Drugs2007，8，4：	1
14	Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure显示文摘	Hamdy NA Kanis JA Beneton Mn		BM J0，310，：	1
15	Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus 显示文摘	van Lierop AH Hamdy NA van der Meer RW	2012	Eur J Endocrinol2012，166，4：	1
16	The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma 显示文摘	Heemstra KA Hamdy NA Romijn JA	2006	Thyroid2006，16，6：	1
17	Downregulation of CASR expression and global loss of parafibromin staining are strong nega- tive determinants of prognosis in parathyroid carcinoma 显示文摘	Witteveen JE Hamdy NA Dekkers OM	2011	Modem Pathology2011，24，5：	1
18	Effect of alfacalcidol on natural course of renal bone disease mild to moderate renal failure 显示文摘	Hamdy NA Kanis JA Beneton M n		BMJ0，310，：	1
19	SerumDickkopf 1 levels in sclerostin deficiency 显示文摘	Van Lierop AH Moester MJ Hamdy NA	2014	J Clin En-docrinol Metab2014，99，2：	1
20	Role of plasma homocysteine and lipoprotein(a) in coronary artery disease显示文摘	Barghash NA Elewa SM Hamdi EA	2004	Br J Biomed Sci2004，61，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示